4,937
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Acetylcholinesterase is not a generic marker of extracellular vesicles

, ORCID Icon, , , , , , , , ORCID Icon & ORCID Icon show all
Article: 1628592 | Received 22 Sep 2018, Accepted 04 Jun 2019, Published online: 03 Jul 2019
 

ABSTRACT

Acetylcholinesterase (AChE) activity is found in abundance in reticulocytes and neurons and was developed as a marker of reticulocyte EVs in the 1970s. Easily, quickly, and cheaply assayed, AChE activity has more recently been proposed as a generic marker for small extracellular vesicles (sEV) or exosomes, and as a negative marker of HIV-1 virions. To evaluate these proposed uses of AChE activity, we examined data from different EV and virus isolation methods using T-lymphocytic (H9, PM1 and Jurkat) and promonocytic (U937) cell lines grown in culture conditions that differed by serum content. When EVs were isolated by differential ultracentrifugation, no correlation between AChE activity and particle count was observed. AChE activity was detected in non-conditioned medium when serum was added, and most of this activity resided in soluble fractions and could not be pelleted by centrifugation. The serum-derived pelletable AChE protein was not completely eliminated from culture medium by overnight ultracentrifugation; however, a serum “extra-depletion” protocol, in which a portion of the supernatant was left undisturbed during harvesting, achieved near-complete depletion. In conditioned medium also, only small percentages of AChE activity could be pelleted together with particles. Furthermore, no consistent enrichment of AChE activity in sEV fractions was observed. Little if any AChE activity is produced by the cells we examined, and this activity was mainly present in non-vesicular structures, as shown by electron microscopy. Size-exclusion chromatography and iodixanol gradient separation showed that AChE activity overlaps only minimally with EV-enriched fractions. AChE activity likely betrays exposure to blood products and not EV abundance, echoing the MISEV 2014 and 2018 guidelines and other publications. Additional experiments may be merited to validate these results for other cell types and biological fluids other than blood.

Acknowledgments

LMJ, CT and MO thank Dr.Kirchhoff (Institute of Molecular Medicine, Ulm, Germany) for providing the pBR-NL43-IRES-eGFP-Nef+ HIV strain.

Authors’ contributions

CT and KWW designed and supervised the study. ZL, LM-J, ES, MJ, DCM, THS, and TS performed the research. NJH, MO, CT, and KWW provided resources. THS, LM-J, CT, and KWW wrote the manuscript. All authors provided feedback and approved the final version.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplementary material

Supplemental data for this article can be accessed here.

Additional information

Funding

This work was funded in part by grants from US National Institutes of Health NIDA (DA040385, to KWW and under subaward from Johns Hopkins University School of Medicine to CT and MO, and DA047807, to KWW); NIA (AG057430, to KWW); and NIMH (MH118164, to KWW); and from INSERM and Institut Curie (CT, LMJ, ES); Fondation ARC pour la recherche sur le Cancer (CT); ANRS (2015-1 CT, LMJ); French National Research Agency (ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043 to CT); and SIDACTION (17-1-AAE-1138 to CT). Additionally, electron microscopy imaging was enabled by the French National Research Agency through the “Investments for the Future” program (France-BioImaging, ANR-10-INSB-04), and PICT-IBiSA, member of the France-BioImaging national research infrastructure, supported by the CelTisPhyBio Labex (N° ANR-10-LBX-0038) part of the IDEX PSL (N°ANR-10-IDEX-0001-02 PSL).